FDA Permits Expanded Access for Investigational Pancreatic Cancer Drug Daraxonrasib MedNews
Today, the U.S. Food and Drug Administration is announcing that it issued a safe to proceed letter to Revolution Medicines, allowing the sponsor to initiate an
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Good morning. Chelsea Cirruzzo filling in here today from D.C., where another fox has